SPHEROMED - Trademark Details
Status: 404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Serial Number
79065696
Registration Number
3983391
Word Mark
SPHEROMED
Status
404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Status Date
2018-10-21
Filing Date
2008-10-21
Registration Number
3983391
Registration Date
2011-06-28
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2011-04-12
Attorney Name
Law Office Assigned Location Code
L40
Employee Name
RIRIE, VERNA BETH
Statements
Goods and Services
Compilation and management of computerized databases; provision of business management information via computer databases
Goods and Services
Scientific and technological services and research and design, namely, database evaluation, design and development; computer diagnostic services; providing reagent sample testing and diagnostic services for others in the field of scientific research; diagnostic testing of humans for medical research purposes; medical research services; medical research in the field of oncology; medical research in the field of disease indications and identification of tumor indications; testing of drugs, biological and chemical preparations for medical research purposes; pharmaceutical research, inspection and development; pharmaceutical drug development services; medical and scientific research, namely, conducting clinical trials concerning biological and chemical preparations and pharmaceuticals; medical and scientific research, namely, researching profiles of biological and chemical preparations, pharmaceuticals, antigens; testing for scientific and medical research purposes of combinations of biological and chemical preparations and pharmaceuticals; testing for medical research purposes to determine the chemo-resistance and chemo-sensitivity of biological and chemical preparations and pharmaceuticals; medical research in the nature of testing the efficacy and toxicity of biological and chemical preparations and pharmaceuticals; medical research in the nature of testing the effects of biological and chemical preparations and pharmaceuticals on cell toxicity levels; medical research in the nature of pharmacokinetic testing of biological and chemical substances and known pharmaceuticals; medical research concerning the absorption, delivery, metabolism, excretion and toxicity testing of biological and chemical preparations and pharmaceuticals; medical and scientific research in the field of pharmaceuticals, genetic changes induced by biological or chemical preparations or pharmaceuticals, and pharmaceutical dosing levels; research and development of pharmaceutical treatment therapies for others; scientific research concerning tumor biology, progression and metastasis; medical research concerning optimal treatment and therapy regimes for individuals; medical research concerning optimal cancer therapy for individuals; research and development of new products for others in relation to prediction of cancer therapy; scientific and medical research in the field of radiotherapy; research, development and design of new radiotherapy products for others; scientific and medical research in the field of radio chemotherapy; research, development and design of new products for others in the field of radio chemotherapy; scientific and medical research in the field of stem cells and biomarker discovery, characterization and development; medical research in the fields of ex-vivo therapies, patient material profiling, tumor profiling, in vitro modeling of tissue and biological systems, tumor modeling, cell culture systems, three-dimensional cell culture systems, and three-dimensional culture of donor and patient cells; laboratory research services, namely, isolation, culture and treatment of donor and patient tissues and cells for medical research purposes; research laboratory services, namely, preparation of cell lines, primary tissues and fluids, and biological material into a format for scientific and medical research purposes; medical research concerning immunohistology, immunohistology preparation and investigation; research laboratory services, namely, creation and preparation of biological material into or onto a format for immunohistology investigation, creation and preparation of biological material on a solid or wax support, preparation of sections or slices of biological material on to slides, all for medical research purposes; medical research concerning small molecule development, preparation and generation, antibody research, development, preparation and generation, and vaccine research, development, preparation and generation; provision of information and data relating to scientific and technological research and development; provision of information and data relating to medical and veterinary research and development; provision of information and data relating to scientific and medical research concerning pharmaceuticals, drug testing, drug discovery and development, treatment and therapies, and testing of biological material
Goods and Services
Medical services; veterinary services; provision of information and data relating to pharmaceuticals, treatment and therapies, all relating to medical and veterinary fields
Pseudo Mark
SPHEROTEC MEDICAL; SPHERO TECHNOLOGICAL MEDICAL
Classification Information
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2018-02-02
Primary Code
035
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2018-02-02
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2018-02-02
Primary Code
044
Correspondences
Name
Jeffrey A. Smith
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
0994402
International Registration Date
2008-10-21
International Publication Date
2009-03-26
International Renewal Date
2018-10-21
Auto Protection Date
2010-09-19
International Status
102 - Death of IR (Dead as a Result of Non-Renewal, Renunciation or Cancellation by Holder of International Registration)
International Status Date
2018-10-21
Priority Claimed In
True
Priority Claimed Date
2008-04-21
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2009-03-19 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2009-03-20 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2009-03-20 | ASSIGNED TO EXAMINER |
| 2009-03-24 | APPLICATION FILING RECEIPT MAILED |
| 2009-03-26 | NON-FINAL ACTION WRITTEN |
| 2009-03-27 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2009-03-27 | REFUSAL PROCESSED BY MPU |
| 2009-03-27 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2009-04-23 | REFUSAL PROCESSED BY IB |
| 2009-09-23 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2009-09-23 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2009-09-24 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2009-09-28 | ASSIGNED TO LIE |
| 2009-09-28 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2009-09-28 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2009-10-21 | SUSPENSION LETTER WRITTEN |
| 2009-10-22 | LETTER OF SUSPENSION MAILED |
| 2010-04-23 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| 2010-08-19 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 2010-08-19 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2010-09-03 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 2010-11-04 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| 2011-03-08 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2011-03-09 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2011-03-23 | NOTICE OF PUBLICATION |
| 2011-03-24 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2011-03-24 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2011-04-12 | PUBLISHED FOR OPPOSITION |
| 2011-04-16 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 2011-06-28 | REGISTERED-PRINCIPAL REGISTER |
| 2011-09-28 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2011-12-01 | FINAL DISPOSITION PROCESSED |
| 2011-12-02 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2013-03-03 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2018-02-02 | CANCELLED SECTION 71 |
| 2018-10-02 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 2018-10-05 | INVALIDATION PROCESSED |
| 2018-10-05 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 2018-12-14 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 2019-05-24 | DEATH OF INTERNATIONAL REGISTRATION |
| 2019-05-24 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
